09/04/24	Affärsvärlden maintains its buy recommendation for Slottsviken after property acquisition	FW
27/09/23	Affärsvärlden maintains its buy recommendation for Slottsviken	FW
30/08/23	Affärsvärlden suggests seven interesting real estate shares	FW

More recommendations

Managers and Directors: Conpharm AB

Manager	Title	Age	Since
Jakob Österberg CEO	Chief Executive Officer	47	01/01/2013

Director	Title	Age	Since
Peter Hamnebo CHM	Chairman	49	01/01/2013
Jakob Österberg BRD	Director/Board Member	47	01/01/2013
Fredrik Lars Josef Österberg CHM	Chairman	51	01/01/2013

More insiders

Other Real Estate Development & Operations

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN HUNG KAI PROPERTIES LIMITED	-2.26%	-0.26%	+34.06%	+14.16%	44.24B
CHINA RESOURCES LAND LIMITED	-2.61%	-1.01%	+25.05%	+2.90%	32.84B
MITSUBISHI ESTATE CO., LTD.	-2.15%	+5.76%	+56.42%	+136.78%	32.22B
EMAAR PROPERTIES	+5.13%	+9.63%	-1.60%	+86.65%	28.15B
MITSUI FUDOSAN CO., LTD.	-2.58%	+2.89%	+14.22%	+60.15%	26.65B
CHINA OVERSEAS LAND & INVESTMENT LIMITED	-2.18%	-1.55%	+9.21%	-14.68%	21.84B
CK ASSET HOLDINGS LIMITED	-1.23%	+3.43%	+37.48%	+4.04%	20.99B
SUMITOMO REALTY & DEVELOPMENT CO., LTD.	-3.61%	+3.68%	+21.85%	+91.59%	21.25B
ALPHA DHABI HOLDING	+8.52%	+11.34%	-30.93%	-54.67%	20.44B
Average	-0.33%	+3.89%	+18.42%	+36.32%	27.62B
Weighted average by Cap.	-0.62%	+3.82%	+21.32%	+39.27%

See all sector performances

Slottsviken Fastighetsaktiebolag (publ), formerly Conpharm AB (publ), is a Sweden-based company involved in real estate sector. The Company owns and manages residential, office and commercial properties in peri-urban locations. Slottsviken Fastighetsaktiebolag (publ) is a real estate company that acquires, manages and develops attractive properties in urban areas with a focus on the Gothenburg region. Its property portfolio includes residential properties; and commercial premises for production, shop/trade, restaurants, industry, workshops, logistics, and offices. The company also invests in securities; and owns and manages intellectual property rights relating to Reumacon and Wartec life science activities.

Employees

Sector

Real Estate Development & Operations

More about the company

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrows Top Investments!

SEIZE THE OFFER!

Market Cap	54M 5.76M 4.96M 4.57M 4.29M 8.05M 544M 8.13M 21.09M 267M 21.61M 21.15M 922M	P/E Ratio 2024	23.1x	P/E Ratio 2025	28.8x
Enterprise Value	105M 11.22M 9.67M 8.9M 8.35M 15.68M 1.06B 15.84M 41.09M 519M 42.09M 41.2M 1.8B	EV / Sales 2024	8.35x	EV / Sales 2025	9.69x
Free-Float	83.79%	Yield 2024	0.3%	Yield 2025	0.3%

05-27	Slottsviken shares trade ex-dividend today on Spotlight at SEK 0.12 per share	FW
05-19	Slottsviken's long-term net asset value edges higher in Q1	FW
04-29	Slottsviken Fastighetsaktiebolag announces Annual dividend, payable on June 02, 2026	CI
02-26	Slottsviken Increases Dividend	FW
02-26	Slottsviken Fastighetsaktiebolag Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
11-24	Slottsviken Increases Net Asset Value in the Third Quarter	FW
11-21	Slottsviken Fastighetsaktiebolag Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
22/08/25	Slottsviken Improves Net Profit in Q2	FW
22/08/25	Slottsviken Fastighetsaktiebolag Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
04/07/25	Slottsviken Acquires Property in Sävenäs	FW
03/06/25	Slottsviken's major shareholder Daniel Stensiö increases his shareholding	FW
02/06/25	Major shareholder Lackarebäck makes a small share purchase in Slottsviken	FW
28/05/25	Slottsviken reports increased net asset value as a result of higher property values	FW

	2024	2025
Net sales	13.08M 1.39M 1.2M 1.11M 1.04M 1.95M 132M 1.97M 5.11M 64.54M 5.23M 5.12M 223M	13.53M 1.44M 1.24M 1.14M 1.07M 2.02M 136M 2.04M 5.29M 66.79M 5.42M 5.3M 231M
Net income	2.78M 297K 256K 235K 221K 415K 28.03M 419K 1.09M 13.72M 1.11M 1.09M 47.49M	2.78M 297K 256K 235K 221K 415K 28.04M 419K 1.09M 13.73M 1.11M 1.09M 47.51M
Net Debt	41.65M 4.44M 3.83M 3.52M 3.3M 6.21M 420M 6.27M 16.27M 206M 16.67M 16.31M 711M	51.19M 5.46M 4.7M 4.33M 4.06M 7.63M 516M 7.71M 20M 253M 20.49M 20.05M 874M

Conpharm AB Stock Swiss Exchange

Stocks

CONP.B

SE0000102840

Real Estate Development & Operations

Valuation: Conpharm AB

Latest news : Conpharm AB

Analysts' recommendations: Conpharm AB

Managers and Directors: Conpharm AB

Other Real Estate Development & Operations

Financials

Company Profile